Testing effectiveness (Phase 2)Ended earlyNCT02090283
What this trial is testing
Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa
Who this might be right for
Epidermolysis Bullosa
Scioderm, Inc. 42